Abstract:There is limited knowledge about the metabolism and function of n-3 very-long-chain polyunsaturated fatty acids (n-3 VLC-PUFAs) with chain lengths ≥24. They are known to be produced endogenously in certain tissues from eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) and not considered to originate directly from dietary sources. The aim of this study was to investigate whether n-3 VLC-PUFAs from dietary sources are bio-available and deposited in tissues of rat, fish and mouse. Rats were fed diets sup… Show more
“…In line with these results, analysis of internal organ health scores and external welfare indicators revealed the same tendency toward improved welfare with increased dietary EPA and DHA content, especially for liver colour, which is considered a visual indicative of fat accumulation [59] and is therefore associated with nutritional disorders [60]. On the other hand, the welfare scorings for skin damage appeared to be marginally higher (worse condition) but not significant in the 3.5% EPA and DHA group, which was unexpected given the demonstrated positive impact of n-3 PUFAs in barrier tissues, such as skin [61]. Although only anecdotical, one potential explanation for these results could be that the fish in the 3.5% EPA and DHA group were substantially bigger and more active at the time of the final sampling and handling may have slightly damaged the skin and had a negative influence on the scoring.…”
The present study evaluated the effects of increasing the dietary levels of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) in Atlantic salmon (Salmo salar) reared in sea cages, in terms of growth performance, welfare, robustness, and overall quality. Fish with an average starting weight of 275 g were fed one of four different diets containing 10, 13, 16, and 35 g/kg of EPA and DHA (designated as 1.0%, 1.3%, 1.6%, and 3.5% EPA and DHA) until they reached approximately 5 kg. The 3.5% EPA and DHA diet showed a significantly beneficial effect on growth performance and fillet quality compared with all other diets, particularly the 1% EPA and DHA diet. Fish fed the diet containing 3.5% EPA and DHA showed 400-600 g higher final weights, improved internal organ health scores and external welfare indicators, better fillet quality in terms of higher visual colour score and lower occurrence of dark spots, and higher EPA and DHA content in tissues at the end of the feeding trial. Moreover, fish fed the 3.5% EPA and DHA diet showed lower mortality during a naturally occurring cardiomyopathy syndrome outbreak, although this did not reach statistical significance. Altogether, our findings emphasise the importance of dietary EPA and DHA to maintain good growth, robustness, welfare, and fillet quality of Atlantic salmon reared in sea cages.
“…In line with these results, analysis of internal organ health scores and external welfare indicators revealed the same tendency toward improved welfare with increased dietary EPA and DHA content, especially for liver colour, which is considered a visual indicative of fat accumulation [59] and is therefore associated with nutritional disorders [60]. On the other hand, the welfare scorings for skin damage appeared to be marginally higher (worse condition) but not significant in the 3.5% EPA and DHA group, which was unexpected given the demonstrated positive impact of n-3 PUFAs in barrier tissues, such as skin [61]. Although only anecdotical, one potential explanation for these results could be that the fish in the 3.5% EPA and DHA group were substantially bigger and more active at the time of the final sampling and handling may have slightly damaged the skin and had a negative influence on the scoring.…”
The present study evaluated the effects of increasing the dietary levels of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) in Atlantic salmon (Salmo salar) reared in sea cages, in terms of growth performance, welfare, robustness, and overall quality. Fish with an average starting weight of 275 g were fed one of four different diets containing 10, 13, 16, and 35 g/kg of EPA and DHA (designated as 1.0%, 1.3%, 1.6%, and 3.5% EPA and DHA) until they reached approximately 5 kg. The 3.5% EPA and DHA diet showed a significantly beneficial effect on growth performance and fillet quality compared with all other diets, particularly the 1% EPA and DHA diet. Fish fed the diet containing 3.5% EPA and DHA showed 400-600 g higher final weights, improved internal organ health scores and external welfare indicators, better fillet quality in terms of higher visual colour score and lower occurrence of dark spots, and higher EPA and DHA content in tissues at the end of the feeding trial. Moreover, fish fed the 3.5% EPA and DHA diet showed lower mortality during a naturally occurring cardiomyopathy syndrome outbreak, although this did not reach statistical significance. Altogether, our findings emphasise the importance of dietary EPA and DHA to maintain good growth, robustness, welfare, and fillet quality of Atlantic salmon reared in sea cages.
“…Dietary VLCPUFA-oil showed no adverse effects, using doses comparable with previous animal studies of VLCPUFAs. 11 , 16 The single-dose oral administration of the VLCPUFA-oil caused a rapid increase in plasma levels of 24:5, followed by increased tissue levels in the retina. Despite the relatively low content of 24:6 in the VLCPUFA-oil, it also increased in the retina, possibly due to conversion of 24:5 by delta-6 desaturase.…”
Section: Discussionmentioning
confidence: 99%
“…Overall, our results confirm the previous studies’ findings concerning the bioavailability and tissue incorporation of orally administered VLCPUFAs. 11 , 16 Until now, most studies on dietary PUFA metabolism have focused on shorter-chain fatty acids (C18-C22), so the detailed metabolism of dietary VLCPUFAs remains largely unknown. 20 Further studies using isotopic labeled VLCPUFAs are needed to better understand their possible interconversion and degradation in various tissues.…”
Section: Discussionmentioning
confidence: 99%
“… 44 The dose and feeding period are comparable with previous animal metabolism studies, using fish oil-derived VLCPUFA concentrate in triglyceride form or dietary DHA. 16 , 45 Each diet contained equally 18.8% kcal from protein, 63.9% kcal from carbohydrate, and 17.2% kcal from fat. After 8 weeks of diet consumption, the 5-h fasted mice were euthanized via intraperitoneal injection of tribromoethanol.…”
“…The severity of these conditions indicates that VLC-FA play an essential role in animals. We have previously demonstrated deposition of n -3 VLC-PUFA in skin tissue after dietary supplementation in Atlantic salmon ( Salmo salar ) and mice ( 29 ) , which may indicate a role of VLC-PUFA in skin. This is an interesting finding, as the importance of VLC-FA in skin has mostly been examined in relation to very-long-chain SFA (VLC-SFA), while the role of VLC-PUFA remains unclear ( 25 , 27 , 29 ) .…”
The purpose of this study was to investigate the effect of dietary n-3 very-long-chain polyunsaturated fatty acids (n-3 VLC-PUFAs) on the maturation and development of skin tissue in juvenile Atlantic salmon (Salmo salar) in vivo, as well as their effects on skin keratocyte and human skin fibroblast cell migration in vitro. Atlantic salmon were fed different dietary levels of n-3 VLC-PUFAs from an initial weight of 6 g to a final weight of 11 g. Changes in skin morphology were analysed at two timepoints during the experiment and the effects on skin tissue fatty acid composition were determined. Additionally, in vitro experiments using human dermal fibroblasts and primary Atlantic salmon keratocytes were conducted to investigate the effect of VLC-PUFAs on the migration capacity of the cells. The results demonstrated that increased dietary levels of n-3 VLC-PUFAs led to an increased epidermis thickness and more rapid scale maturation in Atlantic salmon skin in vivo, leading to a more mature skin morphology, and possibly more robust skin, at an earlier life stage. Additionally, human skin fibroblasts and salmon skin keratocytes supplemented with n-3 VLC-PUFAs in vitro showed more rapid migration, indicating potentially beneficial effects of VLC-PUFAs in wound healing. In conclusion, VLC-PUFAs may have beneficial effects on skin tissue development, function, and integrity.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.